Literature DB >> 25131362

[Extrapulmonary tuberculosis].

W Ketata1, W K Rekik2, H Ayadi2, S Kammoun2.   

Abstract

Each year, there are more than eight million new cases of tuberculosis and 1.3 million deaths. There is a renewed interest in extrapulmonary forms of tuberculosis as its relative frequency increases. Among extrapulmonary organs, pleura and lymph nodes are the most common. Their diagnosis is often difficult and is based on clinical, radiological, bacteriological and histological findings. Extrapulmonary lesions are paucibacillary and samplings, in most cases, difficult to obtain, so diagnosis is often simply presumptive. Nucleic acid amplification tests, which are fast and specific, have greatly facilitated the diagnosis of some forms of extrapulmonary tuberculosis. However, their sensitivity is poor and a negative test does not eliminate the diagnosis. Treatment is the same as for pulmonary forms, but its duration is nine to 12 months for central nervous system and for bone tuberculosis. Corticosteroids are indicated in meningeal and pericardial localizations. Complementary surgery is used for certain complicated forms.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Abdomen; Appareil uro-génital; Bone; Central nervous system; Ganglion; Node; Os; Pleura; Plèvre; Système nerveux central; Tuberculose; Tuberculosis; Uro-genital tract

Mesh:

Year:  2014        PMID: 25131362     DOI: 10.1016/j.pneumo.2014.04.001

Source DB:  PubMed          Journal:  Rev Pneumol Clin        ISSN: 0761-8417


  9 in total

1.  Head-to-head comparison of the efficacy of Xpert MTB/RIF Ultra and Xpert MTB/RIF for the diagnosis of tuberculous pleurisy: A systematic review and meta-analysis.

Authors:  Wenfeng Yu; Yanqin Shen; Pengfei Zhu; Da Chen
Journal:  Medicine (Baltimore)       Date:  2022-05-20       Impact factor: 1.817

2.  Risk Factors of Bone Nonfusion After Spinal Tuberculosis Debridement Bone Graft Fusion and Internal Fixation.

Authors:  Zihan Wei; Ying Zhang; Sizhen Yang; Jiawen Ye; Xu Hu; Tian Li; Tongwei Chu
Journal:  Front Surg       Date:  2022-05-18

3.  [Tuberculosis of the chest wall: Report of a case at the Joseph Ravoahangy Andrianavalona Teaching Hospital, Antananarivo, Madagascar].

Authors:  R N A L Rakotorahalahy; S Randrianandrasana; T Rajaobelison; R A Ralaivao; L Ramiliarijaona; A J C Rakotoarisoa
Journal:  Med Trop Sante Int       Date:  2021-09-23

4.  The circuits of healthcare: Understanding healthcare seeking behaviour-A qualitative study with tuberculosis patients in Lisbon, Portugal.

Authors:  Rafaela M Ribeiro; Philip J Havik; Isabel Craveiro
Journal:  PLoS One       Date:  2021-12-28       Impact factor: 3.240

Review 5.  Xpert MTB/RIF Assay for the Diagnosis of Lymph Node Tuberculosis in Children: A Systematic Review and Meta-Analysis.

Authors:  Hao-Kai Chen; Rui-Si Liu; Yi-Xuan Wang; En-Xiang Quan; Yuan-Hua Liu; Xu-Guang Guo
Journal:  J Clin Med       Date:  2022-08-08       Impact factor: 4.964

6.  [Epidemiological profile and diagnostic and evolutionary features of TB patients at the Diagnostic Centre for Tuberculosis and Respiratory Diseases in Settat, Morocco].

Authors:  Mohamed Chahboune; Mohamed Barkaoui; Younes Iderdar; Nadia Alwachami; Yassmine Mourajid; Mohamed Ifleh; Karima Boumendil; Khadija Bachar; Saad El Madani
Journal:  Pan Afr Med J       Date:  2022-07-07

7.  Application of metagenomic next-generation sequencing in cutaneous tuberculosis.

Authors:  Min Kong; Wei Li; Qingsheng Kong; Haixin Dong; Aizhong Han; Liqing Jiang
Journal:  Front Cell Infect Microbiol       Date:  2022-09-23       Impact factor: 6.073

Review 8.  Left-sided portal hypertension caused by peripancreatic lymph node tuberculosis misdiagnosed as pancreatic cancer: a case report and literature review.

Authors:  Dajun Yu; Xiaolan Li; Jianping Gong; Jinzheng Li; Fei Xie; Jiejun Hu
Journal:  BMC Gastroenterol       Date:  2020-08-18       Impact factor: 3.067

9.  Human Alveolar and Splenic Macrophage Populations Display a Distinct Transcriptomic Response to Infection With Mycobacterium tuberculosis.

Authors:  Lelia Lavalett; Hector Ortega; Luis F Barrera
Journal:  Front Immunol       Date:  2020-04-21       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.